- Home
- DYN vs LION Comparison
DYN vs LION Comparison
Compare DYN & LION Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DYN
- LION
- Stock Information
- Founded
- DYN 1984
- LION 1997
- Country
- DYN United States
- LION United States
- Employees
- DYN N/A
- LION N/A
- Industry
- DYN Medicinal Chemicals and Botanical Products
- LION Movies/Entertainment
- Sector
- DYN Health Care
- LION Consumer Discretionary
- Exchange
- DYN Nasdaq
- LION Nasdaq
- Market Cap
- DYN 1.4B
- LION 1.6B
- IPO Year
- DYN 2020
- LION N/A
- Fundamental
- Price
- DYN $12.50
- LION $6.56
- Analyst Decision
- DYN Strong Buy
- LION Buy
- Analyst Count
- DYN 15
- LION 8
- Target Price
- DYN $36.00
- LION $9.00
- AVG Volume (30 Days)
- DYN 3.0M
- LION 2.3M
- Earning Date
- DYN 07-28-2025
- LION 08-07-2025
- Dividend Yield
- DYN N/A
- LION N/A
- EPS Growth
- DYN N/A
- LION N/A
- EPS
- DYN N/A
- LION N/A
- Revenue
- DYN N/A
- LION $3,986,900,000.00
- Revenue This Year
- DYN N/A
- LION N/A
- Revenue Next Year
- DYN N/A
- LION $7.80
- P/E Ratio
- DYN N/A
- LION N/A
- Revenue Growth
- DYN N/A
- LION 10.89
- 52 Week Low
- DYN $6.36
- LION $5.55
- 52 Week High
- DYN $47.45
- LION $8.50
- Technical
- Relative Strength Index (RSI)
- DYN 70.49
- LION 57.96
- Support Level
- DYN $10.78
- LION $5.65
- Resistance Level
- DYN $12.59
- LION $6.39
- Average True Range (ATR)
- DYN 0.82
- LION 0.29
- MACD
- DYN 0.31
- LION 0.05
- Stochastic Oscillator
- DYN 78.35
- LION 87.26
About DYN Dyne Therapeutics Inc.
Dyne Therapeutics Inc is a clinical-stage neuromuscular disease company focused on discovering and advancing life-transforming therapeutics for people living with genetically driven neuromuscular diseases. Its FORCE platform develops targeted therapeutics that are designed to overcome limitations in delivery to muscle tissue and the central nervous system, or CNS. Its FORCE platform therapeutics consist of a payload that is rationally designed to target the genetic basis of the disease are seeking to treat, a linker, and an antigen-binding fragment, that attaches to the payload using the linker. Its Pipeline includes DYNE-101, DYNE-251, DYNE-302, and DYNE-401.
About LION Lionsgate Studios Corp. Common Shares
Lionsgate Studios Corp is a company encompasses world-class motion picture and television studio operations and the STARZ-branded premium global subscription platforms to bring a unique and varied portfolio of entertainment to consumers around the world. The Studio Business consists of the Motion Picture and Television Production reportable segments, together with substantially all of Lionsgate's corporate general and administrative costs. Motion Picture consists of the development and production of feature films, acquisition of North American and worldwide distribution rights. Television Production consists of the development, production and worldwide distribution of television productions including television series, television movies and mini-series, and non-fiction programming.